India  

Moderna to seek COVID vaccine authorization for teens

Video Credit: Reuters - Politics - Duration: 01:23s - Published
Moderna to seek COVID vaccine authorization for teens

Moderna to seek COVID vaccine authorization for teens

Moderna's COVID-19 vaccine was found to be effective in adolescents aged 12-17 and showed no new or major safety problems in a clinical trial, the developer said on Tuesday, potentially setting the stage for a second vaccine for school-aged children to be authorized in July.

This report produced by Freddie Joyner

Vaccine-makers are racing to get approval for their COVID-19 shots in younger and younger people.

And on Tuesday, Moderna announced it would be the second firm to seek clearance to use their vaccine in school-age children in the U.S. A clinical trial showed Moderna’s shot was effective in adolescents aged 12-17, with no new or major safety problems. The Moderna vaccine – already authorized for adults aged 18 and up – will now go to the U.S. Food and Drug Administration, which could grant emergency use authorization as soon as July.

It took U.S. regulators about a month to review and approve the Pfizer/Biontech shot for ages 12-15.

Moderna's trial studied 3,732 adolescents aged 12 to 17.

Two thirds got the vaccine and one third got a placebo.

Two weeks after the second dose, researchers found no cases of COVID-19 in the vaccine group and four cases in the placebo group.

Children rarely develop COVID-19 symptoms. But they remain at risk of falling seriously ill and can still transmit the virus.

Widely vaccinating kids aged 12 and up could allow U.S. schools and summer camps to relax masking and social distancing measures suggested by the CDC.

Moderna is currently testing its vaccine in children as young as 6 months of age.




You Might Like


💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

'Arguably we shouldn't have gone' - Root on 2021-22 Ashes

Former captain Joe Root says England "arguably" should not have gone on the last Ashes tour of Australia, amid Covid restrictions.
BBC Sport

Food and Drug Administration Food and Drug Administration United States federal agency

Supreme Court Upholds FDA Regulation on Popular Abortion Drug Mifepristone [Video]

Supreme Court Upholds FDA Regulation on Popular Abortion Drug Mifepristone

Supreme Court Upholds , FDA Regulation on Popular , Abortion Drug Mifepristone. On June 13, the Supreme Court ruled against a group of doctors who challenged the Food and Drug Administration's (FDA) regulations on the abortion pill mifepristone. CBS reports that the case once again highlighted abortion access following the conservative majority decision to overturn Roe v. Wade in 2022. The court ruled unanimously that the group of anti-abortion rights doctors and medical associations lacked the legal right to challenge the FDA. . However, the court also did not address whether the FDA's decision to relax the rules for mifepristone's use were lawful. . The latest ruling was authored by Justice Brett Kavanaugh. . Under Article III of the Constitution, a plaintiff's desire to make a drug less available for others does not establish standing to sue. , Justice Brett Kavanaugh writing for the court, via CBS. Nor do the plaintiffs' other standing theories suffice. Therefore, the plaintiffs lack standing to challenge FDA's actions, Justice Brett Kavanaugh writing for the court, via CBS. CBS reports that the ruling does not impact other challenges to the FDA's standing on mifepristone, while preserving access to the popular abortion medication. In 2016 and 2021, the FDA took steps to widen access to mifepristone, which has been taken by over 5 million patients since first being approved in 2000. Those steps included allowing the drug to be taken up to 10 weeks into a pregnancy, reducing the number of in-person doctor visits and permitting it to be sold through the mail.

Credit: Wibbitz Top Stories    Duration: 01:30Published
Microdose Chocolate May Cause Seizures, FDA Warns [Video]

Microdose Chocolate May Cause Seizures, FDA Warns

Microdose Chocolate , May Cause Seizures, FDA Warns. The FDA says that several people in four states have gotten sick after eating Diamond Shruumz chocolate bars. Severe symptoms experienced by the victims include "seizures, central nervous system depression, agitation, abnormal heart rates, hyper/hypotension, nausea and vomiting," CBS News reports. . The chocolate, which is sold across the country, landed six of the eight victims in the hospital. . The company's website says that the chocolate is manufactured with a "primo proprietary blend of nootropic and functional mushrooms.". In 2022, the FDA called nootropics "a term widely used to market unapproved products as 'smart drugs' and 'cognitive enhancers.'". On June 7, the FDA warned parents to keep their kids away from the chocolate which is marketed as candy. . Parents and caregivers should consider discussing the information in this advisory with their children and take extra care to avoid this product being consumed by younger people. , FDA, via statement. Half of the victims were in Arizona, CBS News reports. . While these products claim to contain only natural ingredients and no scheduled drugs, there is clearly something toxic occurring, Steve Dudley, director of the Arizona Poison and Drug Information Center, via news release. We've seen the same phenomenon of people eating the chocolate bar then seizing, losing consciousness, and having to be intubated, Steve Dudley, director of the Arizona Poison and Drug Information Center, via news release

Credit: Wibbitz Top Stories    Duration: 01:30Published
FDA Reverses Ban on Juul E-Cigarettes [Video]

FDA Reverses Ban on Juul E-Cigarettes

FDA Reverses Ban , on Juul E-Cigarettes. On June 6, the Food and Drug Administration announced that it has reversed its ban on Juul e-cigarettes while the agency reviews new information. On June 6, the Food and Drug Administration announced that it has reversed its ban on Juul e-cigarettes while the agency reviews new information. NBC reports that the FDA first ordered Juul to take its product off the market in 2022, however the e-cigarettes have remained on shelves pending the company's appeal. NBC reports that the FDA first ordered Juul to take its product off the market in 2022, however the e-cigarettes have remained on shelves pending the company's appeal. In that time, Juul has maintained its position as the second-most popular e-cigarette in the U.S. The FDA noted that reversing the ban temporarily was not an indication that the company's product would be ultimately cleared. . The FDA noted that reversing the ban temporarily was not an indication that the company's product would be ultimately cleared. . Sales of alternative nicotine products, like e-cigarettes, have continued to grow in the past decade. . In 2023, the Centers for Disease Control and Prevention reported that e-cigarette use had grown by almost 50% between 2020 and 2022. . In 2023, the Centers for Disease Control and Prevention reported that e-cigarette use had grown by almost 50% between 2020 and 2022. . Juul released a statement following the FDA reversal, . ... saying the company looks forward to "re-engaging with the agency on a science- and evidence-based process to pursue a marketing authorization.". We remain confident in the quality and substance of our applications and believe that a full review of the science and evidence will demonstrate that our products meet the statutory standard of being appropriate for the protection of public health, Juul statement, via NBC. We remain confident in the quality and substance of our applications and believe that a full review of the science and evidence will demonstrate that our products meet the statutory standard of being appropriate for the protection of public health, Juul statement, via NBC. 'The Wall Street Journal' reports that Juul has argued that the 2022 ban significantly disrupted the company's finances, resulting in an investor bailout. Currently, the FDA has only granted approval for 23 e-cigarette products, manufactured by only three companies, to be marketed and sold to consumers

Credit: Wibbitz Top Stories    Duration: 01:31Published
FDA Reviewing Data on MDMA for Potential Approval of Groundbreaking PTSD Treatment [Video]

FDA Reviewing Data on MDMA for Potential Approval of Groundbreaking PTSD Treatment

FDA Reviewing Data on MDMA , for Potential Approval of , Groundbreaking PTSD Treatment. 'The Independent' reports that federal health advisers are considering a first-ever approval of MDMA, a psychedelic drug, to treat post traumatic stress disorder (PTSD). 'The Independent' reports that federal health advisers are considering a first-ever approval of MDMA, a psychedelic drug, to treat post traumatic stress disorder (PTSD). The news comes after decades of psychedelic advocates urging regulators to give the drug medical acceptance. . On June 4, the Food and Drug Administration (FDA) called on a group of outside experts to review the latest MDMA research. . The research suggests that when the drug is paired with talk therapy, it can help alleviate PTSD. . However, regulators at the FDA have questioned the reliability of the data, as well as the potential safety risks, which include possible heart problems and addiction. FDA approval could open the door for federal approval to be granted as soon as this summer. . Approval would make MDMA, often referred to as ecstasy or molly, the first illegal psychedelic to receive approval for mainstream medicine. . 'The Independent' reports that a number of psychedelics are expected to receive FDA reviews in the coming years amid interest in their potential to treat depression, anxiety and addiction. 'The Independent' reports that a number of psychedelics are expected to receive FDA reviews in the coming years amid interest in their potential to treat depression, anxiety and addiction. It’s clear that MDMA-assisted therapy would be a welcome addition to the currently available options, Dr. Kelley O'Donnell, a New York University psychiatrist who helped conduct the MDMA studies, via 'The Independent'. I’ve seen firsthand how this treatment can be lifesaving for some, Dr. Kelley O'Donnell, a New York University psychiatrist who helped conduct the MDMA studies, via 'The Independent'

Credit: Wibbitz Top Stories    Duration: 01:30Published
Cucumbers Are Recalled in 14 States [Video]

Cucumbers Are Recalled in 14 States

Cucumbers Are Recalled , in 14 States. Fresh Start Produce Sales in Florida is recalling cucumbers over possible salmonella contamination, 'Newsweek' reports. The 14 states affected by the recall include Alabama, Florida, Georgia, Illinois, Maryland, North Carolina, New Jersey, New York, Ohio, Pennsylvania, South Carolina, Tennessee, Virginia and West Virginia. Only large, whole cucumbers are included in the recall. Mini and English cucumbers are considered safe to eat. The Pennsylvania Department of Agriculture first informed Fresh Start that its product tested positive for salmonella. The FDA is conducting whole genome sequencing to determine if this sample is related to an ongoing salmonella outbreak investigation, Via recall notice. Fresh Start believes it recalled the product before it could make it into consumers' hands. Although these cucumbers are unlikely [to be found] in the marketplace, anyone with the recalled product should not consume it and should destroy and discard it or return it to the place of purchase for a refund, Fresh Start Produce Sales, via statement. Consumers should check with their retailer or place of purchase to determine whether the recalled cucumbers were sold where they shop, Fresh Start Produce Sales, via statement

Credit: Wibbitz Top Stories    Duration: 01:31Published

Centers for Disease Control and Prevention Centers for Disease Control and Prevention United States government public health agency

US Surgeon General Declares Gun Violence in America a ‘Public Health Crisis’ [Video]

US Surgeon General Declares Gun Violence in America a ‘Public Health Crisis’

US Surgeon General , Declares Gun Violence in America , a ‘Public Health Crisis’. U.S. Surgeon General Dr. Vivek Murthy made the declaration in a new advisory released on June 25, CNN reports. It is the first time that a surgeon general has focused on gun violence's "profound consequences" in a national publication. . Over the last decade or two, this problem has been worsening and we have now reached the point where gun violence is the leading cause of death among kids and teens – the leading cause of death. , Dr. Vivek Murthy, to CNN's John Berman. That is something that we should never take as the new normal. There’s nothing normal about that, Dr. Vivek Murthy, to CNN's John Berman. According to Murthy, the advisory is intended to take the polarizing issue of firearms "out of the realm of politics and put it into the realm of public health, which is where it belongs.". According to Murthy, the advisory is intended to take the polarizing issue of firearms "out of the realm of politics and put it into the realm of public health, which is where it belongs.". The advisory highlights measures that Murthy believes can have an impact on gun violence. just as steps to address vehicle crashes and tobacco-related illnesses have in the past. . just as steps to address vehicle crashes and tobacco-related illnesses have in the past. . Historically, we have seen how the release of Surgeon General reports on public health issues such as the dangers of smoking ignited a wave of policy, legal, and public health initiatives.., Dr. Joseph V. Sakran, Brady board chair and chief medical officer, via CNN. ... that saved countless American lives and in this case led to deprogramming our nation from the tobacco industry’s lies. , Dr. Joseph V. Sakran, Brady board chair and chief medical officer, via CNN. We hope this report will have the same resounding impact on the gun violence epidemic, Dr. Joseph V. Sakran, Brady board chair and chief medical officer, via CNN. In 2022, over 48,000 people in America died from gun-related injuries, according to CDC data. In the new advisory, Dr. Murthy said, "It is up to us to take on this generational challenge with the urgency and clarity the moment demands.". The safety and well-being of our children and future generations are at stake, Dr. Vivek Murthy, via advisory

Credit: Wibbitz Top Stories    Duration: 01:31Published

Related videos from verified sources

Moderna Says Its COVID-19 Vaccine Is Safe and Effective in 12- to 17-Year-Olds [Video]

Moderna Says Its COVID-19 Vaccine Is Safe and Effective in 12- to 17-Year-Olds

On Tuesday, Moderna announced the results of their Phase 2 trial of the administration of their COVID-19 vaccine to children ages 12 to 17

Credit: Cover Video STUDIO     Duration: 01:01Published
Florida Could Soon Be Using Moderna Vaccine On Kids After Successful Clinical Trials [Video]

Florida Could Soon Be Using Moderna Vaccine On Kids After Successful Clinical Trials

CBS4's Keith Jones has more on the local vaccination efforts. Read more: https://cbsloc.al/3wz8x0B

Credit: CBS4 Miami     Duration: 03:37Published
Moderna Announces COVID-19 Vaccine 100% Effective In Children As Young As 12 [Video]

Moderna Announces COVID-19 Vaccine 100% Effective In Children As Young As 12

CBS4's Keith Jones reports on the major vaccine milestone.

Credit: CBS4 Miami     Duration: 02:54Published